(UroToday.com) In this session, Dr. Christopher Evans began the session presenting an index case of a man with a PSA of 5.2, who later underwent a prostate biopsy demonstrating Gleason grade Group 1 cancer only. Later, the patient had an Oncotype test done, showing a GPS score of 21. The patient went on to undergo a multiparametric Magnetic resonance imaging (MRI) and was told that there were no signs of any significant cancer and was consequently put on active surveillance protocol, which he has been on for the last two years. The patient is wondering whether he needs a biopsy every two years, or can he have a biomarker test instead of or perhaps a multiparametric MRI reassuring him that he can forgo the biopsy.